Pan-feng Shang-Panfeng - Publications

Global research trends and clinical theme evolution in robot-assisted nephrectomy with venous tumor thrombectomy for renal cell carcinoma: a bibliometric and visualization analysis.

Journal: Journal of robotic surgery

Published: May 18, 2026

Development and multicohort validation of an interpretable postoperative model for intravesical recurrence after radical nephroureterectomy in upper tract urothelial carcinoma.

Journal: World journal of urology

Published: April 27, 2026

A comparison of efficacy and prognosis between RC48 combined immunotherapy and gemcitabine-cisplatin combined immunotherapy in bladder-preserving multimodal therapy for muscle-invasive bladder cancer.

Journal: International urology and nephrology

Published: April 03, 2026

ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancer.

Journal: Cellular signalling

Published: February 26, 2026

Preoperative non-contrast CT-derived adiposity quantity and attenuation predict recurrence-free survival after nephrectomy for localized clear cell renal cell carcinoma.

Journal: International urology and nephrology

Published: December 30, 2025

A FOXO1-G6PC transcriptional axis restrains renal cell carcinoma progression: multi-omics, epigenetic, and mechanistic evidence.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 02, 2025

Corrigendum to "Downregulation of S100A11 promotes T cell infiltration by regulating cancer-associated fibroblasts in prostate cancer" [Int. Immunopharmacol. 128 (2024) 111323].

Journal: International immunopharmacology

Published: August 29, 2025

SERPINH1 derived from cancer-associated fibroblasts promotes epithelial-mesenchymal transition in clear cell renal cell carcinoma.

Journal: Genes and immunity

Published: May 14, 2025

High FSTL1 expression promotes bladder cancer progression by enhancing tumor cell migration.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 24, 2025

Comparative efficacy of transperitoneal and retroperitoneal laparoscopic nephroureterectomy for upper tract urothelial carcinoma: a multicenter propensity score-matched study.

Journal: International urology and nephrology

Published: April 22, 2025

Comparative efficacy of kidney-sparing surgery versus radical nephroureterectomy for high-risk middle-lower ureteral urothelial carcinoma: a retrospective analysis.

Journal: International urology and nephrology

Published: April 14, 2025

Development and validation of a predictive model for postoperative metastasis of upper tract urothelial carcinoma after radical nephroureterectomy and analysis of risk factors for different metastatic sites: a multicenter study.

Journal: International urology and nephrology

Published: December 24, 2024